This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Kendra Debusk: Innovator in Dermatological Treatments
Introduction
Kendra Debusk is a notable inventor based in New Hope, PA (US). She has made significant contributions to the field of dermatology, particularly in the treatment of atopic dermatitis. With a total of 2 patents to her name, her work has garnered attention in the medical community.
Latest Patents
One of Kendra's latest patents is titled "Uses of IL-13 Antagonists for Treating Atopic Dermatitis." This patent outlines methods for treating atopic dermatitis and reducing its severity through the administration of IL-13 antagonists. Her innovative approach offers new hope for patients suffering from this condition.
Career Highlights
Throughout her career, Kendra has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop and refine her groundbreaking ideas in dermatological treatments.
Collaborations
Kendra has collaborated with esteemed colleagues such as Karl Yen and Theodore A. Omachi. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Kendra Debusk is a pioneering inventor whose work in dermatology is making a significant impact. Her patents and collaborations reflect her dedication to improving treatments for atopic dermatitis.